Muscle Aging Science and Translation (MAST)
APRIL 18, 2025 • Joseph B. Martin Conference Center • Boston, MA
A focused meeting on muscle biology, repair, and translation.
Age-related frailty, including sarcopenia, osteoarthritis, and hip fractures, threatens mobility, independence, and quality of life. Despite their prevalence, there are no approved treatments for sarcopenia or muscle preservation during bed rest or hip fracture recovery, and disease-modifying therapies for osteoarthritis remain elusive. With aging populations worldwide, the need for innovation in treatment strategies and clinical development is urgent. This conference brings together researchers and students to discuss emerging solutions and drive collaboration in the fight against muscle aging.
01 · Panel: Opening Talks: A Clinical Research Perspective on Frailty
Roger Fielding, PhD
Professor of Medicine, Tufts University School of Medicine
Douglas Kiel, MD, MPH
Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Shivani Sahni, PhD
Associate Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Yi-Hsiang Hsu, MD, ScD
Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
02 · Flash Talk: Next Generation Therapeutic Approaches
Lada Nuzhna
Founder and Chief Executive Officer, General Control; Director, Impetus Grants
03 · Flash Talk: In Vivo Pooled Screening for Translational Discovery in Osteoarthritis
Francisco LePort, PhD
Co-Founder and Chief Executive Officer, Gordian Biotechnology
04 · Panel: Biotech & Drug Development for Muscle Aging
David Glass, MD
Vice President, Research, Aging and Age-Related Disorders, Regeneron
Anne Ulrike-Trendelenburg, PhD
Director, Diseases of Aging and Regenerative Medicine, Novartis
Andrew Adams, PhD
Group Vice President, Molecule Discovery and Director, Institute of Genetic Medicines, Eli Lilly and Company
Ken Attie, MD
Vice President, Clinical Research, Obesity, Eli Lilly and Company; Chief Medical Officer, Versanis Bio
05 · Panel: Exercise Science for Muscle Longevity
Brad Schoenfeld, PhD
Professor of Exercise Science, Lehman College
Jeff Nippard
Professional Bodybuilder; Science Communicator
Thank you to our sponsors
APRIL 18, 2025 • Joseph B. Martin Conference Center • Boston, MA
A focused meeting on muscle biology, repair, and translation.
Age-related frailty, including sarcopenia, osteoarthritis, and hip fractures, threatens mobility, independence, and quality of life. Despite their prevalence, there are no approved treatments for sarcopenia or muscle preservation during bed rest or hip fracture recovery, and disease-modifying therapies for osteoarthritis remain elusive. With aging populations worldwide, the need for innovation in treatment strategies and clinical development is urgent. This conference brings together researchers and students to discuss emerging solutions and drive collaboration in the fight against muscle aging.
01 · Panel: Opening Talks: A Clinical Research Perspective on Frailty
Shivani Sahni, PhD
Associate Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Yi-Hsiang Hsu, MD, ScD
Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Roger Fielding, PhD
Professor of Medicine, Tufts University School of Medicine
Roger Fielding, PhD
Professor of Medicine, Tufts University School of Medicine
Douglas Kiel, MD, MPH
Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
02 · Flash Talk: Next Generation Therapeutic Approaches
Lada Nuzhna
Founder and Chief Executive Officer, Stealth Biotechnology Company; Director, Impetus Grants
03 · Flash Talk: In Vivo Pooled Screening for Translational Discovery in Osteoarthritis
Francisco LePort, PhD
Co-Founder and Chief Executive Officer, Gordian Biotechnology
04 · Panel: Biotech & Drug Development for Muscle Aging
David Glass, MD
Vice President, Research, Aging and Age-Related Disorders, Regeneron
Anne Ulrike-Trendelenburg, PhD
Director, Diseases of Aging and Regenerative Medicine, Novartis
Andrew Adams, PhD
Group Vice President, Molecule Discovery and Director, Institute of Genetic Medicines, Eli Lilly and Company
Ken Attie, MD
Vice President, Clinical Research, Obesity, Eli Lilly and Company; Chief Medical Officer, Versanis Bio
05 · Panel: Exercise Science for Muscle Longevity
Brad Schoenfeld, PhD
Professor of Exercise Science, Lehman College
Jeff Nippard
Professional Bodybuilder; Science Communicator
SPONSORS
APRIL 18, 2025 • Joseph B. Martin Conference Center • Boston, MA
A focused meeting on muscle biology, repair, and translation.
Age-related frailty, including sarcopenia, osteoarthritis, and hip fractures, threatens mobility, independence, and quality of life. Despite their prevalence, there are no approved treatments for sarcopenia or muscle preservation during bed rest or hip fracture recovery, and disease-modifying therapies for osteoarthritis remain elusive. With aging populations worldwide, the need for innovation in treatment strategies and clinical development is urgent. This conference brings together researchers and students to discuss emerging solutions and drive collaboration in the fight against muscle aging.
01 · Panel: Opening Talks: A Clinical Research Perspective on Frailty
Roger Fielding, PhD
Professor of Medicine, Tufts University School of Medicine
Roger Fielding, PhD
Professor of Medicine, Tufts University School of Medicine
Douglas Kiel, MD, MPH
Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Shivani Sahni, PhD
Associate Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
Yi-Hsiang Hsu, MD, ScD
Assistant Professor of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center
02 · Flash Talk: Next Generation Therapeutic Approaches
Lada Nuzhna
Founder and Chief Executive Officer, Stealth Biotechnology Company; Director, Impetus Grants
03 · Flash Talk: In Vivo Pooled Screening for Translational Discovery in Osteoarthritis
Francisco LePort, PhD
Co-Founder and Chief Executive Officer, Gordian Biotechnology
04 · Panel: Biotech & Drug Development for Muscle Aging
David Glass, MD
Vice President, Research, Aging and Age-Related Disorders, Regeneron
Anne Ulrike-Trendelenburg, PhD
Director, Diseases of Aging and Regenerative Medicine, Novartis
Andrew Adams, PhD
Group Vice President, Molecule Discovery and Director, Institute of Genetic Medicines, Eli Lilly and Company
Ken Attie, MD
Vice President, Clinical Research, Obesity, Eli Lilly and Company; Chief Medical Officer, Versanis Bio
05 · Panel: Exercise Science for Muscle Longevity
Brad Schoenfeld, PhD
Professor of Exercise Science, Lehman College
Jeff Nippard
Professional Bodybuilder; Science Communicator
SPONSORS